Atlas Trials

Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels

Clinical trial NCT00671307 · COMPLETED

Trial details

NCT number
NCT00671307
Sponsor
Critical Biologics Corporation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Low GelsolinTraumaInfectionBurns
Start date
2008-03-01
Primary completion
2010-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.